28
Oct
2025

GMEP medical technology GmbH

Exhibitor at CPHI Frankfurt 2025 stand 3.1A23, Finished Dosage Formulations
About Us

GMEP is an international pharmaceutical company with our innovative respiratory drug Ambrospray. We are looking for distributors worldwide and looking forward to get in contact with new partners.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2022
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1A23, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Ambroxol oral Spray

    Product Ambroxol oral Spray

    Ambrospray®  is the innovative and unique product, it's the only oral spray form of Ambroxol in the world. It is convenient to carry and use, it has accurate drug delivery and take effect very fast, It has a wide target group and usage scenes. It is produced in EU with the best quality. We are looking...